What's in jiangjingting's pipeline?

jiangjingting has 2 drugs in our index: 2 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with jiangjingting's portfolio?

Top competitors by shared drug class: Celgene, Celyad Oncology SA, Chongqing Precision Biotech Co., Ltd, Chuan An Biotechnology Co., Ltd., EdiGene Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/jiangjingting.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

jiangjingting — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

jiangjingting pipeline: 2 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
IL-7/IL-15 pre-treated CD19 cells	IL-7/IL-15 pre-treated CD19 cells	marketed	CAR-T cell therapy	CD19	Oncology
IL-2 pre-treated CD19 cells	IL-2 pre-treated CD19 cells	marketed	Adoptive cell therapy	CD19	Oncology

Therapeutic area mix

Oncology · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Celgene · 1 shared drug class
Celyad Oncology SA · 1 shared drug class
Chongqing Precision Biotech Co., Ltd · 1 shared drug class
Chuan An Biotechnology Co., Ltd. · 1 shared drug class
EdiGene Inc. · 1 shared drug class
Gruppo Italiano Malattie EMatologiche dell'Adulto · 1 shared drug class
Guangzhou Bio-gene Technology Co., Ltd · 1 shared drug class
Beijing Yongtai Ruike Biotechnology Company Ltd · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for jiangjingting:

Cite this brief

Drug Landscape (2026). jiangjingting — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/jiangjingting. Accessed 2026-06-10.